EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 109 filers reported holding EAGLE PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.93 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $189,240 | -18.9% | 12,000 | 0.0% | 0.03% | -17.9% |
| Q2 2023 | $233,280 | -31.5% | 12,000 | 0.0% | 0.04% | -36.1% |
| Q1 2023 | $340,440 | -2.9% | 12,000 | 0.0% | 0.06% | -9.0% |
| Q4 2022 | $350,760 | +10.6% | 12,000 | 0.0% | 0.07% | +11.7% |
| Q3 2022 | $317,000 | -40.5% | 12,000 | 0.0% | 0.06% | -36.8% |
| Q2 2022 | $533,000 | -55.1% | 12,000 | -50.0% | 0.10% | -42.4% |
| Q1 2022 | $1,188,000 | -2.8% | 24,000 | 0.0% | 0.16% | +14.6% |
| Q4 2021 | $1,222,000 | -8.7% | 24,000 | 0.0% | 0.14% | -17.2% |
| Q3 2021 | $1,339,000 | +30.4% | 24,000 | 0.0% | 0.17% | +19.2% |
| Q2 2021 | $1,027,000 | +2.5% | 24,000 | 0.0% | 0.15% | -11.5% |
| Q1 2021 | $1,002,000 | -10.4% | 24,000 | 0.0% | 0.16% | -16.7% |
| Q4 2020 | $1,118,000 | +119.2% | 24,000 | +100.0% | 0.20% | +75.2% |
| Q3 2020 | $510,000 | -55.7% | 12,000 | -50.0% | 0.11% | -59.2% |
| Q2 2020 | $1,152,000 | +4.3% | 24,000 | 0.0% | 0.28% | -17.3% |
| Q1 2020 | $1,104,000 | -23.4% | 24,000 | 0.0% | 0.34% | -1.5% |
| Q4 2019 | $1,442,000 | +6.2% | 24,000 | 0.0% | 0.34% | +1.5% |
| Q3 2019 | $1,358,000 | +1.6% | 24,000 | 0.0% | 0.34% | +4.7% |
| Q2 2019 | $1,336,000 | +10.2% | 24,000 | 0.0% | 0.32% | +8.8% |
| Q1 2019 | $1,212,000 | +25.3% | 24,000 | 0.0% | 0.29% | +9.3% |
| Q4 2018 | $967,000 | -41.9% | 24,000 | 0.0% | 0.27% | -34.2% |
| Q3 2018 | $1,664,000 | -8.4% | 24,000 | 0.0% | 0.41% | +0.2% |
| Q2 2018 | $1,816,000 | +43.6% | 24,000 | 0.0% | 0.41% | +41.7% |
| Q1 2018 | $1,265,000 | -1.3% | 24,000 | 0.0% | 0.29% | +4.0% |
| Q4 2017 | $1,282,000 | -10.4% | 24,000 | 0.0% | 0.28% | -27.5% |
| Q3 2017 | $1,431,000 | -24.4% | 24,000 | 0.0% | 0.38% | -25.5% |
| Q2 2017 | $1,893,000 | -4.9% | 24,000 | 0.0% | 0.51% | -4.8% |
| Q1 2017 | $1,991,000 | +4.6% | 24,000 | 0.0% | 0.54% | -8.5% |
| Q4 2016 | $1,904,000 | +13.3% | 24,000 | 0.0% | 0.59% | -14.4% |
| Q3 2016 | $1,680,000 | +80.5% | 24,000 | 0.0% | 0.69% | +89.0% |
| Q2 2016 | $931,000 | -4.2% | 24,000 | 0.0% | 0.36% | +98.9% |
| Q1 2016 | $972,000 | -54.3% | 24,000 | 0.0% | 0.18% | -49.7% |
| Q4 2015 | $2,128,000 | +19.8% | 24,000 | 0.0% | 0.36% | +0.6% |
| Q3 2015 | $1,777,000 | -8.4% | 24,000 | 0.0% | 0.36% | +1.7% |
| Q2 2015 | $1,941,000 | +93.1% | 24,000 | 0.0% | 0.36% | +93.5% |
| Q1 2015 | $1,005,000 | -51.2% | 24,000 | -81.9% | 0.18% | -52.9% |
| Q4 2014 | $2,058,000 | +22.5% | 132,790 | 0.0% | 0.39% | +19.9% |
| Q3 2014 | $1,680,000 | – | 132,790 | – | 0.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 113,737 | $3,227 | 0.98% |
| Smith, Graham & Co., Investment Advisors, LP | 236,883 | $6,720,371 | 0.82% |
| Capital Impact Advisors, LLC | 13,607 | $386,031 | 0.47% |
| TANG CAPITAL MANAGEMENT LLC | 80,000 | $2,269,600 | 0.34% |
| BRANDES INVESTMENT PARTNERS, LP | 545,050 | $15,463,069 | 0.33% |
| Watershed Asset Management, L.L.C. | 9,496 | $269,402 | 0.33% |
| Jackson Creek Investment Advisors LLC | 25,164 | $714 | 0.30% |
| SummerHaven Investment Management, LLC | 18,178 | $515,710 | 0.30% |
| Virtus Fund Advisers, LLC | 1,117 | $31,689 | 0.22% |
| Virtus Investment Advisers, Inc. | 7,308 | $207,328 | 0.14% |